ACUDERM, INC.
FT LAUDERDALE, FLORIDA

ACUDERM, INC. is a prominent company in the field of dermatologic procedures based in Fort Lauderdale, Florida. Founded on February 1, 1983, its mission has been to deliver high-quality, innovative products and services that offer excellent value to the medical community. Acuderm boasts eight US patents and one international patent for its pioneering advancements in the industry. The company is recognized by major regulatory authorities: it holds FDA certification and complies with UL2601 standards in the USA. Internationally, it maintains ISO 13485 certification and a CE mark in Europe, alongside CMDCAS certification in Canada. Acuderm’s commitment to adhering to evolving domestic and international Regulatory and Quality Assurance standards highlights its dedication to providing superior quality assurance. Under the leadership of key officers such as President Charles R Yeh and Secretary E Nakamura, along with Director J Zalla, Acuderm continues to evolve by introducing new products evaluated and endorsed by Medical Advisors and the Board of Directors. Recently, it expanded services to assist doctors and clinics in setting up new offices efficiently and cost-effectively without compromising on quality. ACUDERM, INC. is incorporated in Florida and registered with multiple regulatory bodies including the US FDA and Florida State Health Department. It maintains compliance with regulatory standards such as FDA 21CFR Part 820, ISO 13485:2003, CMDCAS regulations, CE MDD Annex V, and UL 2601. The company operates from its mailing address at 6555 Powerline Road, Suite 114, Fort Lauderdale, FL, and can be contacted via phone through numbers (954) 733-6935; (800) 327-0015; or (954) 252-4264. For further information on their products and ordering details, visit acuderm.com. The Company's incorporation date is November 16, 1982, under the Filed Number G10785. Its last significant event was recorded on December 16, 2009, with subsequent annual report submission dated February 21, 2024.